Cubist Systematic Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,827
Closed -$6.57M 2020
2025
Q1
$6.57M Buy
+19,827
New +$6.57M 0.04% 365
2024
Q4
Hold
0
1974
2024
Q3
Hold
0
1948
2024
Q2
Sell
-9,013
Closed -$2.41M 2148
2024
Q1
$2.41M Buy
9,013
+7,291
+423% +$1.95M 0.01% 798
2023
Q4
$398K Buy
+1,722
New +$398K ﹤0.01% 1426
2023
Q2
Sell
-18,609
Closed -$4.51M 2707
2023
Q1
$4.51M Buy
18,609
+6,708
+56% +$1.63M 0.03% 669
2022
Q4
$3.45M Buy
11,901
+1,238
+12% +$359K 0.02% 932
2022
Q3
$693K Buy
10,663
+6,963
+188% +$453K ﹤0.01% 2298
2022
Q2
$265K Sell
3,700
-2,201
-37% -$158K ﹤0.01% 3008
2022
Q1
$579K Sell
5,901
-10,943
-65% -$1.07M ﹤0.01% 2419
2021
Q4
$1.43M Buy
16,844
+14,824
+734% +$1.26M 0.01% 1642
2021
Q3
$161K Sell
2,020
-25,644
-93% -$2.04M ﹤0.01% 2641
2021
Q2
$2.7M Buy
+27,664
New +$2.7M 0.03% 901
2021
Q1
Sell
-15,281
Closed -$1.7M 2918
2020
Q4
$1.7M Buy
15,281
+8,168
+115% +$908K 0.02% 1054
2020
Q3
$845K Buy
7,113
+3,963
+126% +$471K 0.01% 1440
2020
Q2
$357K Buy
3,150
+750
+31% +$85K 0.01% 1767
2020
Q1
$160K Sell
2,400
-11,097
-82% -$740K ﹤0.01% 1800
2019
Q4
$1.23M Buy
13,497
+6,404
+90% +$584K 0.02% 1032
2019
Q3
$612K Buy
7,093
+4,377
+161% +$378K 0.01% 1198
2019
Q2
$285K Buy
2,716
+1,228
+83% +$129K 0.01% 1845
2019
Q1
$186K Buy
1,488
+255
+21% +$31.9K 0.01% 1823
2018
Q4
$139K Sell
1,233
-753
-38% -$84.9K 0.01% 1670
2018
Q3
$425K Buy
+1,986
New +$425K 0.02% 929
2018
Q1
Sell
-1,327
Closed -$122K 1967
2017
Q4
$122K Buy
+1,327
New +$122K 0.01% 1656
2015
Q1
Sell
-1,918
Closed -$178K 2001
2014
Q4
$178K Buy
1,918
+1,239
+182% +$115K 0.01% 1554
2014
Q3
$72K Buy
+679
New +$72K ﹤0.01% 1597